Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ROSUVASTATIN CALCIUM, with a corresponding US DMF Number 26540.
Remarkably, this DMF maintains an Active status since its submission on October 11, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 21, 2014, and payment made on November 21, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II